U.S. House · 117th Congress · H.R. 6963
Accelerated Approval Integrity Act of 2022
To amend the Federal Food, Drug, and Cosmetic Act to strengthen requirements for postapproval studies for drugs approved using accelerated approval, and for other purposes.
- Sponsor
- Frank Pallone, Jr.D-NJ-6
- Introduced
- March 7, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these
Signed on later
- Carolyn B. MaloneyD-NY-12March 16, 2022